How do I interpret hepatitis B panel results?

http://www.immunize.org/catg.d/p2021b.htm

How do I interpret hepatitis B panel results?

Interpretation of the hepatitis B panel
Tests Results Interpretation
HBsAg
anti-HBc
anti-HBs		 negative
negative
negative		 susceptible
HBsAg
anti-HBc
anti-HBs		 negative
negative
positive with >10mIU/mL*		 immune due to vaccination
HBsAg
anti-HBc
anti-HBs		 negative
positive
positive		 immune due to natural infection
HBsAg
anti-HBc
IgM anti-HBc
anti-HBs		 positive
positive
positive
negative		 acutely infected
HBsAg
anti-HBc
IgM anti-HBc
anti-HBs		 positive
positive
negative
negative		 chronically infected
HBsAg
anti-HBc
anti-HBs		 negative
positive
negative		 four interpretations possible†
* Postvaccination testing, when it is recommended, should be performed 1–2 months following dose #3.
†1. May be recovering from acute HBV infection.
 2. May be distantly immune and the test is not sensitive enough to detect a very low level of anti-HBs in serum.
 3. May be susceptible with a false positive anti-HBc.
 4. May be chronically infected and have an undetectable level of HBsAg present in the serum.
    
Hepatitis B lab nomenclature
HBsAg: Hepatitis B surface antigen is a marker of infectivity. Its presence indicates either acute or chronic HBV infection.
anti-HBs: Antibody to hepatitis B surface antigen is a marker of immunity. Its presence indicates an immune response to HBV infection, an immune response to vaccination, or the presence of passively acquired antibody. (It is also known as HBsAb, but this abbreviation is best avoided since it is often confused with abbreviations such as HBsAg.)
anti-HBc: Antibody to hepatitis B core antigen is a marker of acute, chronic, or resolved HBV infection. It is not a marker of vaccine-induced immunity. It may be used in prevaccination testing to determine previous exposure to HBV infection. (It is also known as HBcAb, but this abbreviation is best avoided since it is often confused with other abbreviations).
IgM anti-HBc: IgM antibody subclass of anti-HBc. Positivity indicates recent infection with HBV (<6 mos). Its presence indicates acute infection.
IgG anti-HBc: IgG antibody subclass of anti-HBc is a marker of past or current infection with HBV. If it and HBsAg are both positive (in the absence of IgM anti-HBc), this indicates chronic HBV infection.
HBeAg: Hepatitis B "e" antigen is a marker of a high degree of HBV infectivity and it correlates with a high level of HBV replication. It is primarily used to help determine the clinical management of patients with chronic HBV infection.
Anti-HBe: Antibody to hepatitis B "e" antigen may be present in an infected or immune person. In persons with chronic HBV infection, its presence suggests a low viral titer and a low degree of infectivity.
HBV-DNA: HBV Deoxyribonucleic acid is a marker of viral replication. It correlates well with infectivity. It is used to assess and monitor the treatment of patients with chronic hepatitis B infection.

Where can I find a CDC document that states that hepatitis B vaccine doesn't have to be restarted if the series is interrupted?
Discussion regarding an interrupted hepatitis B vaccine schedule can be found in the original hepatitis B vaccine recommendation: "Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States Through Universal Childhood Vaccination: Recommendations of the ACIP" (MMWR 1991;40[RR-13]) under the heading Vaccine Usage. (7/00)

I understand that if a person is HBeAg negative and HBsAg positive s/he is not infectious. Am I wrong?
Yes, you are wrong. HBeAg is an indicator of high viral replication activity, so an individual who is actively replicating hepatitis B virus (HBV) will be highly infectious. HBsAg positivity accompanied by HBeAg negativity indicates continued viral replication, though at a less intense level than if the patient were HBeAg positive. Hence, a person who is HBsAg positive is infectious. (7/00)